Search

Displaying results 9141 - 9150 of 10000 in total
  1. Drug

    E1v1.11

    go.drugbank.com/drugs/DB18363
    Experimental

    E1v1.11 is an antisense oligonucleotide targeting the _SMN2_ gene which is under investigation for the treatment of spinal muscular atrophy (SMA).[L48196]

  2. Drug

    Oleic monoethanolamide

    go.drugbank.com/drugs/DB16495
    Investigational

    Synonyms: N-OEA, N-oleoylethanolamine
  3. Drug

    Motesanib

    go.drugbank.com/drugs/DB05575
    Investigational

  4. Drug

    Aminocandin

    go.drugbank.com/drugs/DB05128
    Experimental

    Aminocandin is a new representative of the echinocandins that could potentially affect the cellular morphology and metabolic status of Candida albicans cells within biofilms.

  5. Drug

    Cobiprostone

    go.drugbank.com/drugs/DB05514
    Investigational

  6. Drug

    Delcasertib

    go.drugbank.com/drugs/DB05560
    Investigational

  7. Drug

    PBT-1033

    go.drugbank.com/drugs/DB05565
    Experimental

  8. Drug

    ATX-201

    go.drugbank.com/drugs/DB05765
    Investigational

    ATX-201 is one of a family of novel compounds that inhibits microtubule polymerization. It is developed by Kythera Biopharmaceuticals, Inc. for the treatment of actinic keratosis. The company announced the decision to discontinue its ATX...

  9. Drug

    PPL-100

    go.drugbank.com/drugs/DB05961
    Investigational

  10. Drug

    BIIB015

    go.drugbank.com/drugs/DB06304
    Investigational

    BIIB015 is a humanized, IgG1 [immunoglobulin G 1], DM4-Conjugated, anti-cripto, monoclonal antibody. It has been investigated for the treatment of subjects with relapsed or refractory solid tumours.